Research reveals compromised transfer of SARS-CoV-2-specific antibodies through placenta

New research led by investigators at Massachusetts General Hospital (MGH) and published in Cell reveals lower than expected transfer of protective SARS-CoV-2 antibodies via the placenta from mothers who are infected in the third trimester. The cause may be alterations to these antibodies after they're produced--a process called glycosylation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3pjp0SX
via IFTTT